Oppenheimer Holdings Inc. (OPY)
NYSE NYSE Primary 
An Oppenheimer Analyst Thinks SpaceX Could Be Worth $10 Trillion in Five Years
Tim Horan, Oppenheimer's satellite and AI infrastructure analyst, went on CNBC Monday to defend a price target that sounds absurd until you back into the math.
SpaceX Headed for $250 or Wildly Overvalued: Oppenheimer and Michael Burry Disagree
The smart money on SpaceX (NASDAQ:SPCX) stock is openly split.
Why Oppenheimer Analysts Are Bullish on SpaceX, the 'East India Company of Space'
An early review of SpaceX stock is in, and it's glowing.
SpaceX stock: Oppenheimer says it's 'undervalued' at $135
Oppenheimer has become the first global brokerage to initiate coverage of SpaceX stock ahead of the company's Nasdaq debut on Friday, issuing an Outperform rating and a $190 price target. Its call implied about a 41% upside that would push SPCX market cap to a whopping $2.5 trillion within the next 12 to 18 months – a bold opening salvo as the most anticipated IPO in market history prepares to begin trading on June 12.
Oppenheimer launches Wall Street's first coverage of SpaceX with bullish outlook
Oppenheimer became the first global brokerage to start coverage of SpaceX , ahead of the rocket and AI company's highly anticipated $75 billion market debut on Friday.
Oppenheimer Says SpaceX Could Disrupt a $1.6 Trillion Industry. AT&T and Verizon Investors Should Be Worried.
Starlink's growing subscriber base could become an issue for legacy broadband providers. Oppenheimer thinks that SpaceX could disrupt the wireless industry by introducing its own line of handheld devices.
Oppenheimer Hikes Palo Alto Networks Price Target to $275: CyberArk Becomes Idira, Identity Security Just Got Real
Oppenheimer analyst Ittai Kidron raised his price target on Palo Alto Networks (NASDAQ:PANW | PANW Price Prediction) to $275 from $245 on May 15, reiterating an Outperform rating.
Oppenheimer Holdings Inc. (OPY) Shareholder/Analyst Call Transcript
Oppenheimer Holdings Inc. (OPY) Shareholder/Analyst Call Transcript
Oppenheimer Holdings: Despite Everything, Things Look Good
Oppenheimer Holdings delivered strong Q1 results, outperforming expectations despite market turbulence and a challenging macro backdrop. OPY's capital markets segment showed robust growth, with operating leverage and increased advisory and ECM revenues driving bottom-line strength. Wealth Management AUM rose approximately 10%, supporting higher advisory fees and commission revenue, though segment pre-tax income declined due to rising compensation.
Oppenheimer Initiates Palantir With Outperform and $200 Price Target: Is the AI Application Leader Worth the Premium?
On April 30, Oppenheimer initiated coverage of Palantir (NASDAQ:PLTR) stock with an Outperform rating and a $200 price target.
Oppenheimer Upgrades Blackstone to Outperform, Calling It the Premier Franchise at a Bargain Price
Blackstone (NYSE:BX | BX Price Prediction) stock is up roughly 2% in early Monday trading after Oppenheimer upgraded shares to Outperform, calling the world's largest alternative asset manager a “premier franchise at a very attractive valuation.
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript
Jade Biosciences, Inc. (JBIO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Prepared Remarks Transcript
